Candida vulvovaginitis secondary prevention

Revision as of 18:24, 20 October 2016 by Dima Nimri (talk | contribs)
Jump to navigation Jump to search

Candidiasis Main page

Patient Information

Overview

Causes

Classification

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]

Overview

Secondary Prevention

References

  1. 1.0 1.1 Sobel JD (2007). "Vulvovaginal candidosis". Lancet. 369 (9577): 1961–71. doi:10.1016/S0140-6736(07)60917-9. PMID 17560449.
  2. 2.0 2.1 Fong IW (1992). "The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole". Genitourin Med. 68 (3): 174–6. PMC 1194850. PMID 1607194.
  3. 3.0 3.1 Shihadeh AS, Nawafleh AN (2000). "The value of treating the male partner in vaginal candidiasis". Saudi Med J. 21 (11): 1065–7. PMID 11360070.
  4. 4.0 4.1 Bisschop MP, Merkus JM, Scheygrond H, van Cutsem J (1986). "Co-treatment of the male partner in vaginal candidosis: a double-blind randomized control study". Br J Obstet Gynaecol. 93 (1): 79–81. PMID 3510660.

Template:WH Template:WS